Literature DB >> 19278421

TGF-beta1 dampens the susceptibility of dendritic cells to environmental stimulation, leading to the requirement for danger signals for activation.

Tomoyuki Ohtani1, Masato Mizuashi, Satoshi Nakagawa, Yoshinori Sasaki, Taku Fujimura, Ryuhei Okuyama, Setsuya Aiba.   

Abstract

In contrast to its favourable effects on Langerhans cell (LC) differentiation, transforming growth factor (TGF)-beta1 has been reported to prevent dendritic cells from maturing in response to tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta, or lipopolysaccharide (LPS). We first characterized the effects of TGF-beta1 on dendritic cell function by testing the response of TGF-beta1-treated monocyte-derived dendritic cells (MoDCs) to maturation stimuli that LCs receive in the epidermis, namely, haptens, ATP and ultraviolet (UV). TGF-beta1 treatment, which augmented E-cadherin and down-regulated dendritic cell-specific ICAM3-grabbing non-integrin on MoDCs, significantly suppressed their CD86 expression and hapten-induced expression of IL-1beta and TNF-alpha mRNA and protein. As TGF-beta1-treated MoDCs lacked Langerin expression, we demonstrated the suppressive effects of TGF-beta1 on haematopoietic progenitor cell-derived dendritic cells expressing both CD1a and Langerin. These suppressive effects of TGF-beta1 increased with the duration of treatment. Furthermore, TGF-beta1-treated MoDCs became resistant to apoptosis/necrosis induced by high hapten, ATP or UV doses. This was mainly attributable to dampened activation of p38 mitogen-activated protein kinase (MAPK) in TGF-beta1-treated MoDCs. Notably, although ATP or hapten alone could only induce CD86 expression weakly and could not augment the allogeneic T-cell stimulatory function of TGF-beta1-treated MoDCs, ATP and hapten synergized to stimulate these phenotypic and functional changes. Similarly, 2,4-dinitro, 1-chlorobenzene (DNCB) augmented the maturation of TGF-beta1-treated MoDCs upon co-culture with a keratinocyte cell line, in which ATP released by the hapten-stimulated keratinocytes synergized with the hapten to induce their maturation. These data may suggest that TGF-beta1 protects LCs from being overactivated by harmless environmental stimulation, while maintaining their ability to become activated in response to danger signals released by keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19278421      PMCID: PMC2673361          DOI: 10.1111/j.1365-2567.2008.02919.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  46 in total

Review 1.  Tolerogenic dendritic cells.

Authors:  Ralph M Steinman; Daniel Hawiger; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  Moderate skin sensitizers can induce phenotypic changes on in vitro generated dendritic cells.

Authors:  M J Staquet; M Sportouch; C Jacquet; D Schmitt; J Guesnet; J Péguet-Navarro
Journal:  Toxicol In Vitro       Date:  2004-08       Impact factor: 3.500

3.  Phenotypic and functional characteristics of in vivo-activated Langerhans cells.

Authors:  S Aiba; S I Katz
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

4.  TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis.

Authors:  E Riedl; H Strobl; O Majdic; W Knapp
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

5.  Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity.

Authors:  Daniel H Kaplan; Mathew C Jenison; Sem Saeland; Warren D Shlomchik; Mark J Shlomchik
Journal:  Immunity       Date:  2005-12       Impact factor: 31.745

6.  TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors.

Authors:  H Strobl; E Riedl; C Scheinecker; C Bello-Fernandez; W F Pickl; K Rappersberger; O Majdic; W Knapp
Journal:  J Immunol       Date:  1996-08-15       Impact factor: 5.422

7.  p38 Mitogen-Activated protein kinase mediates dual role of ultraviolet B radiation in induction of maturation and apoptosis of monocyte-derived dendritic cells.

Authors:  Satoshi Nakagawa; Tomoyuki Ohtani; Masato Mizuashi; Zia U A Mollah; Yumiko Ito; Hachiro Tagami; Setsuya Aiba
Journal:  J Invest Dermatol       Date:  2004-08       Impact factor: 8.551

8.  Interleukin-1 beta and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently.

Authors:  H Ozawa; S Nakagawa; H Tagami; S Aiba
Journal:  J Invest Dermatol       Date:  1996-03       Impact factor: 8.551

9.  Nickel and DNCB induce CCR7 expression on human dendritic cells through different signalling pathways: role of TNF-alpha and MAPK.

Authors:  Fanny Boislève; Saadia Kerdine-Römer; Nathalie Rougier-Larzat; Marc Pallardy
Journal:  J Invest Dermatol       Date:  2004-09       Impact factor: 8.551

10.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.

Authors:  P Boukamp; R T Petrussevska; D Breitkreutz; J Hornung; A Markham; N E Fusenig
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

View more
  16 in total

1.  Secondary lymphoid organ homing phenotype of human myeloid dendritic cells disrupted by an intracellular oral pathogen.

Authors:  Brodie Miles; Ibrahim Zakhary; Ahmed El-Awady; Elizabeth Scisci; Julio Carrion; John C O'Neill; Aaron Rawlings; J Kobi Stern; Cristiano Susin; Christopher W Cutler
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

Review 2.  Dendritic cell control of tolerogenic responses.

Authors:  Santhakumar Manicassamy; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

3.  Severe dermatitis with loss of epidermal Langerhans cells in human and mouse zinc deficiency.

Authors:  Tatsuyoshi Kawamura; Youichi Ogawa; Yuumi Nakamura; Satoshi Nakamizo; Yoshihiro Ohta; Hajime Nakano; Kenji Kabashima; Ichiro Katayama; Schuichi Koizumi; Tatsuhiko Kodama; Atsuhito Nakao; Shinji Shimada
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

Review 4.  Dendritic cells as gatekeepers of tolerance.

Authors:  Ari Waisman; Dominika Lukas; Björn E Clausen; Nir Yogev
Journal:  Semin Immunopathol       Date:  2016-07-25       Impact factor: 9.623

5.  Cooperative regulation of NOTCH1 protein-phosphatidylinositol 3-kinase (PI3K) signaling by NOD1, NOD2, and TLR2 receptors renders enhanced refractoriness to transforming growth factor-beta (TGF-beta)- or cytotoxic T-lymphocyte antigen 4 (CTLA-4)-mediated impairment of human dendritic cell maturation.

Authors:  Devram Sampat Ghorpade; Srini V Kaveri; Jagadeesh Bayry; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2011-07-15       Impact factor: 5.157

6.  Autocrine/paracrine TGF-β1 inhibits Langerhans cell migration.

Authors:  Aleh Bobr; Botond Z Igyarto; Krystal M Haley; Ming O Li; Richard A Flavell; Daniel H Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

7.  Tumor-promoting role of TGFβ1 signaling in ultraviolet B-induced skin carcinogenesis is associated with cutaneous inflammation and lymph node migration of dermal dendritic cells.

Authors:  Anand Ravindran; Javed Mohammed; Andrew J Gunderson; Xiao Cui; Adam B Glick
Journal:  Carcinogenesis       Date:  2013-12-20       Impact factor: 4.944

8.  Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro.

Authors:  André Said; Stephanie Bock; Gerrit Müller; Günther Weindl
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

9.  The late endosomal adaptor molecule p14 (LAMTOR2) regulates TGFβ1-mediated homeostasis of Langerhans cells.

Authors:  Florian Sparber; Christoph H Tripp; Kerstin Komenda; Julia M Scheffler; Björn E Clausen; Lukas A Huber; Nikolaus Romani; Patrizia Stoitzner
Journal:  J Invest Dermatol       Date:  2014-07-31       Impact factor: 8.551

10.  TGFβ1 overexpression by keratinocytes alters skin dendritic cell homeostasis and enhances contact hypersensitivity.

Authors:  Javed Mohammed; Andrew J Gunderson; Hong-Hanh Khong; Richard D Koubek; Mark C Udey; Adam B Glick
Journal:  J Invest Dermatol       Date:  2012-07-26       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.